← United States · Coverage record
US · SEC FORM 4
Lantheus Holdings, Inc.
LNTH · Nasdaq · CIK 0001521036 · Healthcare · Drug Manufacturers—Specialty & Generic
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
14 Form 4 transaction lines observed in the same window
0 sales · 14 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2021-03-05 · Maeusli Heinz Christoph.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 3,783,610
- Previous report
- 4,036,832
- Avg daily volume
- 1,049,857
- Days to cover
- 3.6
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2021-03-05 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 18.60 | USD 18,600 | SEC filing ↗ |
| 2021-02-26 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 18.02 | USD 18,020 | SEC filing ↗ |
| 2021-02-19 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 19.39 | USD 19,390 | SEC filing ↗ |
| 2021-02-12 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 20.03 | USD 20,030 | SEC filing ↗ |
| 2021-02-05 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 17.94 | USD 17,940 | SEC filing ↗ |
| 2021-01-29 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 16.13 | USD 16,130 | SEC filing ↗ |
| 2021-01-22 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 15.29 | USD 15,290 | SEC filing ↗ |
| 2021-01-15 | Maeusli Heinz Christoph | Purchase (P) | Common Stock | 1,000 | USD 15.80 | USD 15,800 | SEC filing ↗ |
Form 4 evidence
34 transaction lines in the latest 365-day window; 485 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Marshall Robert J. Jr. | Tax withholding (F) | Common Stock | 721 | USD 100.96 | USD 72,792 | SEC filing ↗ |
| 2026-08-17 | Dinkelborg Ludger | Tax withholding (F) | Common Stock | 2,536 | USD 100.91 | USD 255,908 | SEC filing ↗ |
| 2026-08-17 | Brown Kimberly | Tax withholding (F) | Common Stock | 463 | USD 100.91 | USD 46,721 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Marshall Robert J. Jr. | Tax withholding (F) | Common Stock | 721 | USD 100.96 | USD 72,792 | SEC filing ↗ |
| 2026-08-17 | Dinkelborg Ludger | Tax withholding (F) | Common Stock | 2,536 | USD 100.91 | USD 255,908 | SEC filing ↗ |
| 2026-08-17 | Brown Kimberly | Tax withholding (F) | Common Stock | 463 | USD 100.91 | USD 46,721 | SEC filing ↗ |
| 2026-05-14 | Heino Mary Anne | Tax withholding (F) | Common Stock | 1,227 | USD 96.67 | USD 118,614 | SEC filing ↗ |
| 2026-05-14 | Ber Gerard | Tax withholding (F) | Common Stock | 381 | USD 96.67 | USD 36,831 | SEC filing ↗ |
| 2026-05-14 | Thrall James H | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Pruden Gary J | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Morrow Phuong Khanh | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | McHugh Julie | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Maeusli Heinz Christoph | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | LENO SAM R | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | EASTLAND JULIA MARIE | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Ber Gerard | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Baylor-Henry Minnie | Award / grant (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-17 | Niedzwiecki Daniel | Tax withholding (F) | Common Stock | 1,911 | USD 83.82 | USD 160,180 | SEC filing ↗ |
| 2026-03-05 | Niedzwiecki Daniel | Tax withholding (F) | Common Stock | 1,283 | USD 76.31 | USD 97,906 | SEC filing ↗ |
| 2026-03-05 | Niedzwiecki Daniel | Award / grant (A) | Common Stock | 36,692 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-05 | Morgan Amanda Michelle | Tax withholding (F) | Common Stock | 595 | USD 76.31 | USD 45,404 | SEC filing ↗ |
| 2026-03-05 | Morgan Amanda Michelle | Award / grant (A) | Common Stock | 26,208 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-05 | Marshall Robert J. Jr. | Tax withholding (F) | Common Stock | 1,182 | USD 76.31 | USD 90,198 | SEC filing ↗ |
| 2026-03-05 | Marshall Robert J. Jr. | Award / grant (A) | Common Stock | 38,002 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-05 | Dinkelborg Ludger | Award / grant (A) | Common Stock | 20,966 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-05 | Brown Kimberly | Tax withholding (F) | Common Stock | 133 | USD 76.31 | USD 10,149 | SEC filing ↗ |
| 2026-03-05 | Brown Kimberly | Award / grant (A) | Common Stock | 6,158 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-02 | Niedzwiecki Daniel | Tax withholding (F) | Common Stock | 8,259 | USD 76.30 | USD 630,162 | SEC filing ↗ |
| 2026-03-02 | Niedzwiecki Daniel | Award / grant (A) | Common Stock | 5,169 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-02 | Morgan Amanda Michelle | Tax withholding (F) | Common Stock | 3,336 | USD 76.30 | USD 254,537 | SEC filing ↗ |
| 2026-03-02 | Morgan Amanda Michelle | Award / grant (A) | Common Stock | 2,782 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-02 | Marshall Robert J. Jr. | Tax withholding (F) | Common Stock | 10,652 | USD 76.30 | USD 812,748 | SEC filing ↗ |
| 2026-03-02 | Marshall Robert J. Jr. | Award / grant (A) | Common Stock | 8,491 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | LNTH |
| CIK | 0001521036 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2835 In Vitro & In Vivo Diagnostic Substances |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 485 transaction lines from 2020-02-19 to 2026-08-31 8 P purchase lines · 233 S sale lines · 244 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.